Portfolio Holdings Detail for ISIN IE00B6SPMN59
Stock Name / Fund iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares VI Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF Ticker SPMV(USD) LSE
ETF Ticker IBCK(EUR) F
ETF Ticker MVUS.MI(EUR) CXE
ETF Ticker SPLVz(CHF) CXE
ETF Ticker SPMV.LS(USD) CXE
ETF Ticker MVUS(EUR) ETF Plus
ETF Ticker SPMV(EUR) ETF Plus
ETF Ticker SPMV.L(GBP) LSE

Holdings detail for VRTX

Stock Name	Vertex Pharmaceuticals Inc
Ticker	VRTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92532F1003
LEI	54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY: (RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
Why This Biotech Company Could Be a Growth Stock Powerhouse: Key PointsThis biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. - 2025-09-17 06:10:00
3 Absurdly Cheap Stocks to Buy for the Long Haul: Key PointsThese stocks are all down for the year, and things could get worse before they get better. - 2025-09-12 08:30:00
My 2 Favorite Stocks to Buy Right Now: Key PointsAmazon has multiple moats and paths to grow. - 2025-08-31 05:51:00
Capital Group Growth ETF Experiences Big Inflow: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $162.3 million dollar inflow -- that's a 1.1% increase week over week i - 2025-08-29 11:52:16
Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
2 Growth Stocks That Are No-Brainer Buys Right Now: Key PointsVertex Pharmaceuticals' recent dip presents an excellent buying opportunity, given its promising prospects. - 2025-08-15 09:30:00
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
The Smartest Growth Stocks to Buy With $1,000 Right Now: Key PointsVertex Pharmaceuticals' recent sell-off was overdone. - 2025-08-09 05:46:00
5 Top Stocks to Buy in August: Key PointsThe pullback in Netflix, Costco, and ASML is a buying opportunity. - 2025-08-08 07:45:00
Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 14:19:48
Wednesday's ETF with Unusual Volume: LSGR: The Natixis Loomis Sayles Focused Growth ETF is seeing unusually high volume in afternoon trading Wednesday, with over 805,000 shares traded versus three month average volume of about 45,000. Shares of LSGR were up about 0.4% on the day. Components of that ETF with the highest - 2025-08-06 13:11:25
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:43:55
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:20:27
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:31:46
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:01:41
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:50:42
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:02:58
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 05:54:32
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 04:21:54
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 02:12:19
Stocks Pressured by Disappointing US Service Sector News: The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.62%. September E-mini S&P futures (ESU25 ) are down -0.55%, and September E-mini Nasdaq futures... - 2025-08-05 19:47:15

iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc) VRTX holdings

Date	Number of VRTX Shares Held	Base Market Value of VRTX Shares	Local Market Value of VRTX Shares	Change in VRTX Shares Held	Change in VRTX Base Value	Current Price per VRTX Share Held	Previous Price per VRTX Share Held
2025-09-30 (Tuesday)	27,301	USD 10,692,164	USD 10,692,164
2025-09-29 (Monday)	27,261	USD 10,776,546	USD 10,776,546	0	USD 261,024	USD 395.31	USD 385.735
2025-09-26 (Friday)	27,261	USD 10,515,522	USD 10,515,522	0	USD 105,364	USD 385.735	USD 381.87
2025-09-25 (Thursday)	27,261	USD 10,410,158	USD 10,410,158	40	USD 158,185	USD 381.87	USD 376.62
2025-09-24 (Wednesday)	27,221	USD 10,251,973	USD 10,251,973	-55,537	USD -21,784,476	USD 376.62	USD 387.11
2025-09-18 (Thursday)	82,758	USD 32,036,449	USD 32,036,449	0	USD -3,311	USD 387.11	USD 387.15
2025-09-17 (Wednesday)	82,758	USD 32,039,760	USD 32,039,760	0	USD -348,411	USD 387.15	USD 391.36
2025-09-16 (Tuesday)	82,758	USD 32,388,171	USD 32,388,171	-720	USD -436,213	USD 391.36	USD 393.21
2025-09-15 (Monday)	83,478	USD 32,824,384	USD 32,824,384	720	USD 173,870	USD 393.21	USD 394.53

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00B6SPMN59

Show aggregate share trades of VRTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-25 BUY 40 381.870* 464.98
2025-09-24 SELL -55,537 376.620* 465.51 Profit of 25,853,216 on sale
2025-09-16 SELL -720 391.360* 466.94 Profit of 336,196 on sale
2025-09-15 BUY 720 393.210* 467.40
2025-09-12 SELL -363 394.530* 467.85 Profit of 169,830 on sale
2025-09-09 SELL -260 396.480* 469.26 Profit of 122,008 on sale
2025-07-30 SELL -910 469.160* 469.34 Profit of 427,101 on sale
2025-07-29 BUY 3,360 468.410* 469.35
2025-07-16 SELL -1,800 469.550* 469.39 Profit of 844,895 on sale
2025-07-14 SELL -240 472.350* 469.40 Profit of 112,656 on sale
2025-07-11 SELL -360 468.850* 469.40 Profit of 168,986 on sale
2025-07-10 SELL -121 479.530* 469.34 Profit of 56,790 on sale
2025-07-09 SELL -240 478.965* 469.27 Profit of 112,625 on sale
2025-07-07 BUY 120 459.410* 469.36
2025-07-03 SELL -1,800 459.620* 469.49 Profit of 845,091 on sale
2025-07-02 SELL -240 457.030* 469.58 Profit of 112,700 on sale
2025-06-23 SELL -240 443.540* 470.27 Profit of 112,866 on sale
2025-06-20 SELL -120 440.870* 470.49 Profit of 56,459 on sale
2025-06-18 SELL -232 448.400* 470.82 Profit of 109,229 on sale
2025-06-16 SELL -1,440 450.910* 471.18 Profit of 678,501 on sale
2025-06-13 SELL -6,128 455.450* 471.30 Profit of 2,888,131 on sale
2025-06-12 SELL -5,400 460.060* 471.39 Profit of 2,545,487 on sale
2025-06-11 SELL -240 452.440* 471.53 Profit of 113,168 on sale
2025-06-06 BUY 360 450.500* 472.06
2025-06-05 BUY 480 443.820* 472.28
2025-05-28 SELL -360 445.100* 473.63 Profit of 170,506 on sale
2025-05-27 BUY 360 446.000* 473.86
2025-05-23 SELL -1,080 436.000* 474.51 Profit of 512,467 on sale
2025-05-22 BUY 240 434.030* 474.86
2025-05-20 BUY 1,080 447.180* 475.44
2025-05-16 SELL -299 438.650* 476.08 Profit of 142,349 on sale
2025-05-15 BUY 480 434.380* 476.46
2025-05-14 SELL -3,240 421.160* 476.96 Profit of 1,545,357 on sale
2025-05-13 BUY 240 432.000* 477.37
2025-05-12 BUY 596 439.370* 477.73
2025-05-09 SELL -480 424.990* 478.22 Profit of 229,545 on sale
2025-05-08 BUY 360 429.600* 478.68
2025-05-07 SELL -600 434.820* 479.10 Profit of 287,457 on sale
2025-04-30 SELL -120 509.500* 478.45 Profit of 57,414 on sale
2025-04-28 SELL -720 496.490* 478.01 Profit of 344,170 on sale
2025-04-23 BUY 120 492.420* 477.54
2025-04-15 BUY 1,560 500.490* 476.79
2025-04-14 BUY 240 495.830* 476.57
2025-04-09 SELL -708 482.300* 476.43 Profit of 337,309 on sale
2025-04-08 BUY 610 472.370* 476.47
2025-04-04 BUY 708 474.620* 476.52
2025-04-02 BUY 343 483.490* 476.43
2025-04-01 SELL -1,062 484.740* 476.33 Profit of 505,863 on sale
2025-03-31 BUY 5,576 484.820* 476.22
2025-03-28 BUY 708 492.690* 476.01
2025-03-27 BUY 1,383 502.550* 475.67
2025-03-26 BUY 3,529 500.280* 475.34
2025-03-25 BUY 2,412 509.040* 474.89
2025-03-24 SELL -354 511.740* 474.40 Profit of 167,936 on sale
2025-03-21 BUY 5,925 503.200* 474.00
2025-03-19 BUY 316 512.520* 472.95
2025-03-17 SELL -654 513.760* 471.79 Profit of 308,550 on sale
2025-03-14 SELL -327 504.770* 471.30 Profit of 154,116 on sale
2025-03-13 SELL -327 502.920* 470.83 Profit of 153,962 on sale
2025-03-12 SELL -654 495.420* 470.46 Profit of 307,680 on sale
2025-03-07 BUY 981 488.290* 469.42
2025-02-28 BUY 981 479.790* 468.35
2025-02-26 BUY 1,308 479.100* 468.05
2025-02-21 BUY 1,962 484.240* 467.28
2025-02-18 BUY 654 462.110* 467.03
2025-02-11 BUY 1,630 455.220* 468.04
2025-02-07 BUY 652 469.320* 467.96
2025-02-06 BUY 326 481.160* 467.66
2025-02-05 BUY 978 488.440* 467.16
2025-02-04 BUY 326 482.280* 466.79
2025-01-31 SELL -654 461.680* 466.83 Profit of 305,308 on sale
2025-01-29 SELL -652 441.520* 468.28 Profit of 305,321 on sale
2024-12-10 SELL -326 469.220* 471.67 Profit of 153,764 on sale
2024-12-09 SELL -326 473.980* 471.59 Profit of 153,739 on sale
2024-11-27 SELL -652 464.560* 474.50 Profit of 309,373 on sale
2024-11-21 SELL -1,304 450.370* 478.07 Profit of 623,403 on sale
2024-11-20 SELL -652 451.230* 479.56 Profit of 312,674 on sale
2024-11-18 SELL -652 467.010* 482.32 Profit of 314,471 on sale
2024-11-12 SELL -1,956 490.000* 481.81 Profit of 942,411 on sale
2024-11-08 SELL -5,216 516.740* 479.31 Profit of 2,500,081 on sale
2024-11-07 SELL -2,282 502.450* 477.53 Profit of 1,089,723 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-25	BUY	40	381.870*	464.98
2025-09-24	SELL	-55,537	376.620*	465.51 Profit of 25,853,216 on sale
2025-09-16	SELL	-720	391.360*	466.94 Profit of 336,196 on sale
2025-09-15	BUY	720	393.210*	467.40
2025-09-12	SELL	-363	394.530*	467.85 Profit of 169,830 on sale
2025-09-09	SELL	-260	396.480*	469.26 Profit of 122,008 on sale
2025-07-30	SELL	-910	469.160*	469.34 Profit of 427,101 on sale
2025-07-29	BUY	3,360	468.410*	469.35
2025-07-16	SELL	-1,800	469.550*	469.39 Profit of 844,895 on sale
2025-07-14	SELL	-240	472.350*	469.40 Profit of 112,656 on sale
2025-07-11	SELL	-360	468.850*	469.40 Profit of 168,986 on sale
2025-07-10	SELL	-121	479.530*	469.34 Profit of 56,790 on sale
2025-07-09	SELL	-240	478.965*	469.27 Profit of 112,625 on sale
2025-07-07	BUY	120	459.410*	469.36
2025-07-03	SELL	-1,800	459.620*	469.49 Profit of 845,091 on sale
2025-07-02	SELL	-240	457.030*	469.58 Profit of 112,700 on sale
2025-06-23	SELL	-240	443.540*	470.27 Profit of 112,866 on sale
2025-06-20	SELL	-120	440.870*	470.49 Profit of 56,459 on sale
2025-06-18	SELL	-232	448.400*	470.82 Profit of 109,229 on sale
2025-06-16	SELL	-1,440	450.910*	471.18 Profit of 678,501 on sale
2025-06-13	SELL	-6,128	455.450*	471.30 Profit of 2,888,131 on sale
2025-06-12	SELL	-5,400	460.060*	471.39 Profit of 2,545,487 on sale
2025-06-11	SELL	-240	452.440*	471.53 Profit of 113,168 on sale
2025-06-06	BUY	360	450.500*	472.06
2025-06-05	BUY	480	443.820*	472.28
2025-05-28	SELL	-360	445.100*	473.63 Profit of 170,506 on sale
2025-05-27	BUY	360	446.000*	473.86
2025-05-23	SELL	-1,080	436.000*	474.51 Profit of 512,467 on sale
2025-05-22	BUY	240	434.030*	474.86
2025-05-20	BUY	1,080	447.180*	475.44
2025-05-16	SELL	-299	438.650*	476.08 Profit of 142,349 on sale
2025-05-15	BUY	480	434.380*	476.46
2025-05-14	SELL	-3,240	421.160*	476.96 Profit of 1,545,357 on sale
2025-05-13	BUY	240	432.000*	477.37
2025-05-12	BUY	596	439.370*	477.73
2025-05-09	SELL	-480	424.990*	478.22 Profit of 229,545 on sale
2025-05-08	BUY	360	429.600*	478.68
2025-05-07	SELL	-600	434.820*	479.10 Profit of 287,457 on sale
2025-04-30	SELL	-120	509.500*	478.45 Profit of 57,414 on sale
2025-04-28	SELL	-720	496.490*	478.01 Profit of 344,170 on sale
2025-04-23	BUY	120	492.420*	477.54
2025-04-15	BUY	1,560	500.490*	476.79
2025-04-14	BUY	240	495.830*	476.57
2025-04-09	SELL	-708	482.300*	476.43 Profit of 337,309 on sale
2025-04-08	BUY	610	472.370*	476.47
2025-04-04	BUY	708	474.620*	476.52
2025-04-02	BUY	343	483.490*	476.43
2025-04-01	SELL	-1,062	484.740*	476.33 Profit of 505,863 on sale
2025-03-31	BUY	5,576	484.820*	476.22
2025-03-28	BUY	708	492.690*	476.01
2025-03-27	BUY	1,383	502.550*	475.67
2025-03-26	BUY	3,529	500.280*	475.34
2025-03-25	BUY	2,412	509.040*	474.89
2025-03-24	SELL	-354	511.740*	474.40 Profit of 167,936 on sale
2025-03-21	BUY	5,925	503.200*	474.00
2025-03-19	BUY	316	512.520*	472.95
2025-03-17	SELL	-654	513.760*	471.79 Profit of 308,550 on sale
2025-03-14	SELL	-327	504.770*	471.30 Profit of 154,116 on sale
2025-03-13	SELL	-327	502.920*	470.83 Profit of 153,962 on sale
2025-03-12	SELL	-654	495.420*	470.46 Profit of 307,680 on sale
2025-03-07	BUY	981	488.290*	469.42
2025-02-28	BUY	981	479.790*	468.35
2025-02-26	BUY	1,308	479.100*	468.05
2025-02-21	BUY	1,962	484.240*	467.28
2025-02-18	BUY	654	462.110*	467.03
2025-02-11	BUY	1,630	455.220*	468.04
2025-02-07	BUY	652	469.320*	467.96
2025-02-06	BUY	326	481.160*	467.66
2025-02-05	BUY	978	488.440*	467.16
2025-02-04	BUY	326	482.280*	466.79
2025-01-31	SELL	-654	461.680*	466.83 Profit of 305,308 on sale
2025-01-29	SELL	-652	441.520*	468.28 Profit of 305,321 on sale
2024-12-10	SELL	-326	469.220*	471.67 Profit of 153,764 on sale
2024-12-09	SELL	-326	473.980*	471.59 Profit of 153,739 on sale
2024-11-27	SELL	-652	464.560*	474.50 Profit of 309,373 on sale
2024-11-21	SELL	-1,304	450.370*	478.07 Profit of 623,403 on sale
2024-11-20	SELL	-652	451.230*	479.56 Profit of 312,674 on sale
2024-11-18	SELL	-652	467.010*	482.32 Profit of 314,471 on sale
2024-11-12	SELL	-1,956	490.000*	481.81 Profit of 942,411 on sale
2024-11-08	SELL	-5,216	516.740*	479.31 Profit of 2,500,081 on sale
2024-11-07	SELL	-2,282	502.450*	477.53 Profit of 1,089,723 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	253,408	88	822,586	30.8%
2025-09-18	262,277	45	831,580	31.5%
2025-09-17	158,866	890	1,012,591	15.7%
2025-09-16	233,484	702	769,823	30.3%
2025-09-15	385,606	97	605,410	63.7%
2025-09-12	198,306	54	325,925	60.8%
2025-09-11	217,651	160	455,823	47.7%
2025-09-10	441,550	65	640,409	68.9%
2025-09-09	216,563	711	395,377	54.8%
2025-09-08	285,371	226	594,102	48.0%
2025-09-05	209,916	9	413,663	50.7%
2025-09-04	236,777	2,164	365,713	64.7%
2025-09-03	212,085	7	457,751	46.3%
2025-09-02	318,587	425	689,371	46.2%
2025-08-29	136,055	7	344,317	39.5%
2025-08-28	189,040	229	437,536	43.2%
2025-08-27	204,685	373	919,772	22.3%
2025-08-26	195,209	380	616,641	31.7%
2025-08-25	205,216	929	405,536	50.6%
2025-08-22	187,538	366	477,729	39.3%
2025-08-21	357,256	454	694,264	51.5%
2025-08-20	304,195	196	620,591	49.0%
2025-08-19	193,253	370	598,168	32.3%
2025-08-18	197,043	357	581,908	33.9%
2025-08-15	213,454	413	509,240	41.9%
2025-08-14	299,335	536	798,768	37.5%
2025-08-13	342,897	6,746	694,047	49.4%
2025-08-12	361,071	536	689,425	52.4%
2025-08-11	478,787	177	1,141,772	41.9%
2025-08-08	382,688	480	1,467,480	26.1%
2025-08-07	802,775	500	1,747,924	45.9%
2025-08-06	1,070,384	29,978	2,256,489	47.4%
2025-08-05	2,087,742	66,027	4,981,303	41.9%
2025-08-04	329,631	253	766,131	43.0%
2025-08-01	290,545	239	729,079	39.9%
2025-07-31	227,826	151	513,336	44.4%
2025-07-30	134,793	234	361,144	37.3%
2025-07-29	124,474	331	372,446	33.4%
2025-07-28	125,989	264	519,868	24.2%
2025-07-25	136,582	104	432,897	31.6%
2025-07-24	144,869	169	321,736	45.0%
2025-07-23	182,307	1,460	370,788	49.2%
2025-07-22	193,759	402	450,155	43.0%
2025-07-21	174,382	14,621	318,671	54.7%
2025-07-18	203,357	10,091	296,802	68.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares VI Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300VML6THE3JJOS76
ETF Ticker	SPMV(USD) LSE
ETF Ticker	IBCK(EUR) F
ETF Ticker	MVUS.MI(EUR) CXE
ETF Ticker	SPLVz(CHF) CXE
ETF Ticker	SPMV.LS(USD) CXE
ETF Ticker	MVUS(EUR) ETF Plus
ETF Ticker	SPMV(EUR) ETF Plus
ETF Ticker	SPMV.L(GBP) LSE